Ignite Creation Date:
2024-05-06 @ 1:37 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04070768
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-13
First Post:
2019-08-26
Brief Title:
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin GO and Venetoclax in Patients With Relapsed or Refractory CD33 Acute Myeloid LeukemiaBig Ten Cancer Research Consortium BTCRC-AML17-113
Sponsor:
John Quigley
Organization:
Big Ten Cancer Research Consortium